{'text': 'ALTTO Trial Finds Dual Anti-HER2 Therapy No Better Than Trastuzumab Alone', 'publisher': {'href': 'https://ascopost.com', 'title': 'The ASCO Post'}, 'created_at': 'Tue, 10 Jun 2014 07:00:00 GMT', 'description': 'ALTTO Trial Finds Dual Anti-HER2 Therapy No Better Than Trastuzumab Alone  The ASCO Post', 'url': 'https://news.google.com/rss/articles/CBMitgFBVV95cUxNYUtqZzl6bkdBRHhaZWY1N2YtWnpWVFFDUGNxQm5tUmIxUXREa19yV21DdnBmendnUFk2YVNJVERoVFVQN28xX3VMclo0bnJCVE1SRUFmczFoRXRNdkdQTnBhWmZvNGxwck5oMkpMVURHb0taS2ZfR2FmcGVnS1ViOElzRHpRU3VseERXVXBUNnU3dnh0bHV0WVBwek1zb3h1V3EyR1ZHLVJjY3dFaF9iZ3RvdU9QUQ?oc=5&hl=en-US&gl=US&ceid=US:en'}
